COVID-19疫苗:过敏患者接种疫苗的耐受性
Natalie Kogseder1, Viktoria Puxkandl1,2, Wolfram Hötzenecker1,2,3
1Department for Dermatology and Venerology, Kepler University Hospital, 4020 Linz, Austria.
Vaccines
|September 27, 2025
概括
对于过敏和先前过敏症患者来说,COVID-19疫苗接种是安全的. 抗组胺前期治疗可能会减少副作用,但先前对疫苗的过敏反应需要谨慎.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和免疫学 过敏和免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- COVID-19疫苗引入了不确定性和犹,特别是在害怕过敏反应的过敏患者中.
- 接受过敏特异性免疫疗法 (SIT) 的患者被评估了他们对COVID-19疫苗的反应.
- 由于对该群体疫苗安全性的担忧,需要在现实世界中收集数据.
研究的目的:
- 评估COVID-19疫苗在接受SIT的显著过敏患者的安全性和不良反应.
- 在这个特定的患者群体中确定不良反应的危险因素和保护措施.
主要方法:
- 在SIT上对57名过敏患者的图表审查,包括并发症,IgE,三酶和HADS得分.
- 对COVID-19疫苗接种情况和报告的不良事件的问卷分析.
- 评估过去的过敏反应和前期药物使用情况.
主要成果:
- 93%的患者接种了COVID-19疫苗,57%的人报告了不良反应,大多数是非特异性 (一般疾病症状).
- 一个1级过敏反应记录在一个患者之前的疫苗反应和高的疫苗接种前焦虑.
- 抗组胺前期治疗与较少的非特异性疫苗接种后反应相关.
结论:
- 对于具有严重过敏和过敏过敏史的人来说,COVID-19疫苗似乎是安全的.
- 以前对疫苗接种过敏反应可能表明COVID-19疫苗反应的风险更高.
- 抗组胺前期治疗可以减轻过敏患者的副作用;建议进行进一步的前性研究.
相关概念视频
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Allergic Reactions
32.0K
Overview
32.0K
Hypersensitivities
7.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
Vaccinations
51.3K
Overview
51.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Cross-reactivity
32.8K
Overview
32.8K


